Trial Search Results
Myoelectric GutPrint-Crohn's Disease
A feasibility study for assessing and recording myoelectric activity in patients for early detection of flare in patients with Crohn's disease and differentiating the myoelectric signals from Crohn's disease patients in remission state and healthy controls.
Stanford is currently accepting patients for this trial.
Collaborator: The Leona M. and Harry B. Helmsley Charitable Trust
- Device: G-Tech Gutcheck Myoelectric recording device
- Patients with Crohn's disease and healthy subjects above the age of 18 who are able to
give consent and follow direction.
- Patients or subjects under the age of 18, pregnant, and those unable to give consent
or follow direction.
- Healthy subjects with gastrointestinal symptoms or history of gastrointestinal
- Patients with severe Crohn's disease due to complexity of disease, complication, and
potential needs for surgery.
- Patients with bowel surgeries due to potential impact on the G-Tech results. For
similar reasons we will exclude patients on new medications (e.g. within 3 months of
enrollment) known to alter GI motility but we will not exclude patients on stable
doses or chronic GI motility agents as this mimics "real world" in which the G-Tech
patch will be used and we can learn the stability of the motility recordings over time
in stable patients.
Ages Eligible for Study
18 Years - 75 Years
Genders Eligible for Study